| Dr Michael James Bodman, DPM | |
|
21245 Lorain Rd, Suite 115, Fairview Park, OH 44126-2146 | |
| (440) 356-1989 | |
| (440) 356-5944 |
| Full Name | Dr Michael James Bodman |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 24 Years |
| Location | 21245 Lorain Rd, Fairview Park, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386615144 | NPI | - | NPPES |
| 341944827 | Other | OH | AETNA |
| 480033770 | Other | OH | RAILROAD MEDICARE |
| 000000210952 | Other | OH | BLUE CROSS AND BLUE SHIELD |
| 2250184 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | 36003254 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Bodman Podiatry Associates Inc | 9739211509 | 2 |
News Archive
African-American political leaders, union members, ministers and community activists are meeting Monday, December 14th to create and implement a strategy to combat the deadly HIV/AIDS virus in the African-American Community.
For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis.
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.
Taking methotrexate or anti-TNFs is associated with a reduction in risk of cardiovascular disease in people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
› Verified 1 days ago
| Provider Name | Dr Bodman Podiatry Associates Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215008735 PECOS PAC ID: 9739211509 Enrollment ID: O20100714000112 |
News Archive
African-American political leaders, union members, ministers and community activists are meeting Monday, December 14th to create and implement a strategy to combat the deadly HIV/AIDS virus in the African-American Community.
For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis.
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.
Taking methotrexate or anti-TNFs is associated with a reduction in risk of cardiovascular disease in people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael James Bodman, DPM 21245 Lorain Rd, Suite 115, Fairview Park, OH 44126-2146 Ph: (440) 356-1989 | Dr Michael James Bodman, DPM 21245 Lorain Rd, Suite 115, Fairview Park, OH 44126-2146 Ph: (440) 356-1989 |
News Archive
African-American political leaders, union members, ministers and community activists are meeting Monday, December 14th to create and implement a strategy to combat the deadly HIV/AIDS virus in the African-American Community.
For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis.
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.
Taking methotrexate or anti-TNFs is associated with a reduction in risk of cardiovascular disease in people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
› Verified 1 days ago
John P Ellis, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 21992 Lorain Rd, Fairview Park, OH 44126 Phone: 440-333-7300 Fax: 440-995-1234 | |
Dr. Raymond Randall Alferink, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 4492 W 220th St, Fairview Park, OH 44126 Phone: 440-734-2228 Fax: 440-734-1793 | |
Fairview Podiatry Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 21475 Lorain Rd, Fairview Park, OH 44126 Phone: 440-356-1118 | |
Dr Bodman Podiatry Associates Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 21245 Lorain Road, Suite 115, Fairview Park, OH 44126 Phone: 440-356-1989 Fax: 440-356-5944 | |
Dr. Myron A Bodman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 21245 Lorain Rd, Suite 115, Fairview Park, OH 44126 Phone: 440-356-1989 Fax: 440-356-5944 | |
John Mario Cuffari, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 21992 Lorain Rd, Fairview Park, OH 44126 Phone: 440-333-7300 Fax: 440-333-7308 |